Lecanemab: Promising Cure or Expensive Gamble?
The debate over lecanemab, one of the first Alzheimer’s drugs to slow cognitive decline, is heating up.
Recent Posts
- Nature’s Response to Human Expansion
- Boost Your Child’s Literacy with Comics
- The Next Gold Rush in Space
- Beam Me Down: Breaking Barriers in Solar Energy
- WeCanReason Speakers’ Weekly Update
- Mars Mission Hits a Snag
- See what leaders in science, secularism, critical thinking, and skepticism did last week
- The Pompeii Discovery Changing Modern Construction
